Basic Information
AlcaSynn Pharmaceuticals GmbH focuses on small molecules of the morphinan group. In 2006, AlcaSynn was acquired by Sanochemia Pharmazeutika.
Sanochemia Pharmazeutika
Austria
15~50 people
March 08, 2004
office@alcasynn.com